So, when considering a company, one of the first things you'll want to look at is its competitive advantage, or moat. Like ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Eli Lilly (LLY) announced on Thursday that its newly approved weight loss pill Foundayo (orforglipron) will be available across U.S. retail pharmacies starting today, setting up a battle with Novo ...

Eli Lilly remains a Buy despite a recent 12% price decline, supported by strategic developments and valuation upside, even as it faces challenges. LLY faces near-term headwinds from Zepbound price ...

This is read by an automated voice. Please report any issues or inconsistencies here. More Altadena homeowners have taken some step toward recovery, jumping from only about 30% of homeowners in August ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By ...

The Middle East war has depleted a key part of the United States’ missile defense system in the region. To rebuild, the U.S. needs to go through China. In just over a month of war, Iran has targeted ...

Eli Lilly’s LLY0.57%increase; green up pointing triangle late-stage study of the efficacy and safety of a treatment for type 2 diabetes has produced positive results. Achieve-4, the longest phase 3 ...

Eli Lilly (LLY) reported Q4 revenue of $19.29B up 42.6% YoY, with Mounjaro generating $7.41B (up 110%) and Zepbound adding $4.26B (up 123%). Novo Nordisk (NVO) posted Q4 revenue down 7.6% YoY and cut ...

Eli Lilly and Company (LLY) announced on Monday that it has entered into an agreement to acquire Orna Therapeutics, a biotechnology firm focused on cell therapies. Orna shareholders could receive up ...